Gunnar Boysen

3.5k total citations
97 papers, 2.7k citations indexed

About

Gunnar Boysen is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Gunnar Boysen has authored 97 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 33 papers in Cancer Research and 17 papers in Pharmacology. Recurrent topics in Gunnar Boysen's work include Carcinogens and Genotoxicity Assessment (22 papers), Pharmacogenetics and Drug Metabolism (17 papers) and DNA Repair Mechanisms (12 papers). Gunnar Boysen is often cited by papers focused on Carcinogens and Genotoxicity Assessment (22 papers), Pharmacogenetics and Drug Metabolism (17 papers) and DNA Repair Mechanisms (12 papers). Gunnar Boysen collaborates with scholars based in United States, United Kingdom and Canada. Gunnar Boysen's co-authors include James A. Swenberg, Stephen S. Hecht, Brian F. Pachkowski, Jun Nakamura, Grover P. Miller, Nadia I. Georgieva, Vernon E. Walker, Leonard B. Collins, Azemat Jamshidi‐Parsian and Richard J. Albertini and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Gunnar Boysen

95 papers receiving 2.7k citations

Peers

Gunnar Boysen
Matthew Bryant United States
Serrine S. Lau United States
Pramod Upadhyaya United States
G.A.S. Ansari United States
Fong‐Fong Chu United States
John H.N. Meerman Netherlands
William H. Bisson United States
Kenneth W. Turteltaub United States
Gunnar Boysen
Citations per year, relative to Gunnar Boysen Gunnar Boysen (= 1×) peers Jagadeesan Nair

Countries citing papers authored by Gunnar Boysen

Since Specialization
Citations

This map shows the geographic impact of Gunnar Boysen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Boysen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Boysen more than expected).

Fields of papers citing papers by Gunnar Boysen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gunnar Boysen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Boysen. The network helps show where Gunnar Boysen may publish in the future.

Co-authorship network of co-authors of Gunnar Boysen

This figure shows the co-authorship network connecting the top 25 collaborators of Gunnar Boysen. A scholar is included among the top collaborators of Gunnar Boysen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunnar Boysen. Gunnar Boysen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kirman, Christopher R., et al.. (2025). Human health risk assessment for exposures to 1,3-butadiene in the United States with input from an independent science advisory panel. Regulatory Toxicology and Pharmacology. 160. 105819–105819. 2 indexed citations
2.
Boysen, Gunnar, Ludmil B. Alexandrov, Raheleh Rahbari, et al.. (2025). Investigating the origins of the mutational signatures in cancer. Nucleic Acids Research. 53(1). 2 indexed citations
3.
Wongsurawat, Thidathip, Piroon Jenjaroenpun, Azemat Jamshidi‐Parsian, et al.. (2023). Exploiting nanopore sequencing for characterization and grading of IDH‐mutant gliomas. Brain Pathology. 34(1). e13203–e13203. 8 indexed citations
4.
Miousse, Isabelle R., Gunnar Boysen, Candace L. Williams, et al.. (2023). Climate Change and New Challenges for Rural Communities: Particulate Matter Matters. Sustainability. 15(23). 16192–16192. 3 indexed citations
5.
Jenkins, Samir V., Shruti Shah, Azemat Jamshidi‐Parsian, et al.. (2023). Abstract 1088: Acquired radiation resistance induces thiol-dependent cisplatin cross-resistance. Cancer Research. 83(7_Supplement). 1088–1088. 1 indexed citations
6.
Wang, Zeyuan, William E. Fantegrossi, Swati Nagar, et al.. (2022). Similar 5F-APINACA Metabolism between CD-1 Mouse and Human Liver Microsomes Involves Different P450 Cytochromes. Metabolites. 12(8). 773–773. 1 indexed citations
7.
Miles, Tiffany K., Susan Russell, Brian Koss, et al.. (2020). Delivery of phosphatidylethanolamine blunts stress in hepatoma cells exposed to elevated palmitate by targeting the endoplasmic reticulum. Cell Death Discovery. 6(1). 8–8. 21 indexed citations
8.
Jenjaroenpun, Piroon, Thidathip Wongsurawat, Trudy M. Wassenaar, et al.. (2020). Decoding the epitranscriptional landscape from native RNA sequences. Nucleic Acids Research. 49(2). e7–e7. 186 indexed citations
9.
Nookaew, Intawat, Piroon Jenjaroenpun, Pengcheng Wang, et al.. (2020). Detection and Discrimination of DNA Adducts Differing in Size, Regiochemistry, and Functional Group by Nanopore Sequencing. Chemical Research in Toxicology. 33(12). 2944–2952. 21 indexed citations
10.
Boysen, Gunnar, Avichai Shimoni, Ivetta Danylesko, Nira Varda‐Bloom, & Arnon Nagler. (2019). A simplified method for detection of N ‐terminal valine adducts in patients receiving treosulfan. Rapid Communications in Mass Spectrometry. 33(21). 1635–1642. 9 indexed citations
11.
Cárdenas, Víctor M., Ruiqi Cen, Lori Fischbach, et al.. (2019). Use of Electronic Nicotine Delivery Systems (ENDS) by pregnant women I: Risk of small-for-gestational-age birth. Tobacco Induced Diseases. 17(May). 44–44. 58 indexed citations
12.
Kim, So Young, Jessica H. Hartman, Drew R. Jones, et al.. (2013). Metabolism of R- and S-Warfarin by CYP2C19 into Four Hydroxywarfarins. Drug Metabolism Letters. 6(3). 157–164. 40 indexed citations
13.
Georgieva, Nadia I., et al.. (2012). Exposure profiling of reactive compounds in complex mixtures. Toxicology. 313(2-3). 145–150. 12 indexed citations
15.
Jones, Drew R., Gunnar Boysen, & Grover P. Miller. (2011). Novel multi-mode ultra performance liquid chromatography–tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma. Journal of Chromatography A. 1 indexed citations
16.
Jones, Drew R., So Young Kim, Gunnar Boysen, Chul‐Ho Yun, & Grover P. Miller. (2010). Contribution of Three CYP3A Isoforms to Metabolism of R- and S-Warfarin. Drug Metabolism Letters. 4(4). 213–219. 14 indexed citations
18.
Watters, Joanne L., Jessie A. Satia, Kerry-Ann da Costa, et al.. (2009). Comparison of three oxidative stress biomarkers in a sample of healthy adults. Biomarkers. 14(8). 587–595. 20 indexed citations
19.
Takahashi, Nobuyuki, et al.. (2006). Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate. Kidney International. 71(3). 266–271. 126 indexed citations
20.
Boysen, Gunnar, Nadia I. Georgieva, Patricia B. Upton, et al.. (2004). Analysis of Diepoxide-Specific Cyclic N -Terminal Globin Adducts in Mice and Rats after Inhalation Exposure to 1,3-Butadiene. Cancer Research. 64(23). 8517–8520. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026